Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Biosimilars lower costs but don't significantly improve access.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Dutasteride may help reduce brain inflammation and improve cognition.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

New progesterone-based compounds can block male hormones.

Finasteride, a drug, can block the seizure-preventing effects of a hormone called progesterone in mice.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Six existing drugs may help block virus entry in COVID-19.

Baricitinib may effectively treat oral lichen planus.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

BMS-470539 reduces skin fibrosis and inflammation.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

A new compound shows promise as a topical treatment for hair loss.

Overexpressing follistatin in mice delays wound healing and reduces scar size.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.